Christine F. Heinzle

Feldkirch, 6800, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Volatilomic Signatures of Parental and Oxaliplatin-Resistant HCT116 Colon Cancer Cell Lines.

Volatilomic Signatures of Parental and Oxaliplatin-Resistant HCT116 Colon Cancer Cell Lines.

Journal: International journal of molecular sciences

Published: May 18, 2026

Circulating Human Epididymis Protein 4 Predicts 10-Year Mortality and Major Adverse Cardiovascular Events in Patients With Peripheral Artery Disease.

Circulating Human Epididymis Protein 4 Predicts 10-Year Mortality and Major Adverse Cardiovascular Events in Patients With Peripheral Artery Disease.

Journal: European journal of clinical investigation

Published: March 06, 2026

Angiopoietin-like protein 2 and mortality in patients with heart failure-Results from an observational study.

Angiopoietin-like protein 2 and mortality in patients with heart failure-Results from an observational study.

Journal: European journal of clinical investigation

Published: August 11, 2025

Clinical Prognostic Significance of LRG1 in Metastatic Breast Cancer.

Clinical Prognostic Significance of LRG1 in Metastatic Breast Cancer.

Journal: Oncology research and treatment

Published: July 31, 2025

Leucine-rich α-2 glycoprotein 1 is associated with increased mortality risk in patients with peripheral artery disease.

Leucine-rich α-2 glycoprotein 1 is associated with increased mortality risk in patients with peripheral artery disease.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: June 04, 2025

The differential effects of CBD and CBDA on viability and mRNA expression in colorectal cancer cells.

The differential effects of CBD and CBDA on viability and mRNA expression in colorectal cancer cells.

Journal: Journal of cannabis research

Published: April 17, 2025

Serum leucine-rich α-2 glycoprotein 1 predicts 10-year mortality and vascular events in coronary angiography patients.

Serum leucine-rich α-2 glycoprotein 1 predicts 10-year mortality and vascular events in coronary angiography patients.

Journal: Atherosclerosis

Published: April 02, 2025

Evaluation of Circulating Glypican-4 in Patients with ESKD.

Evaluation of Circulating Glypican-4 in Patients with ESKD.

Journal: Kidney360

Published: December 06, 2024

Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis.

Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis.

Journal: Scientific reports

Published: April 24, 2024

Coronary Event Risk Test (CERT) as a Risk Predictor for the 10-Year Clinical Outcome of Patients with Peripheral Artery Disease.

Coronary Event Risk Test (CERT) as a Risk Predictor for the 10-Year Clinical Outcome of Patients with Peripheral Artery Disease.

Journal: Journal of clinical medicine

Published: July 26, 2023

Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure.

Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure.

Journal: Clinical biochemistry

Published: June 28, 2023

Myricetin attenuates hypoxia-induced inflammation in human adipocytes.

Myricetin attenuates hypoxia-induced inflammation in human adipocytes.

Journal: Molecular biology reports

Published: June 15, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026